Rationale Behind the Clinical Development of Combination Immunotherapy for Pancreatic Cancer

Part of the Surgical Grand Rounds Series - Lei Zheng, Md, PhD, discusses immunotherapy in pancreatic cancer, focuses on attacking T Cells, and reviews effective treatment options.

Created by

Johns Hopkins Greater Washington Area

Related Presenters

Lei Zheng, MD, PhD

Lei Zheng, MD, PhD

Associate Professor of Oncology

Expertise Anal Cancer, Bile Duct Cancer, Carcinoid Syndrome, Carcinoid Tumors, Cholangiocarcinoma, Colon Cancer, Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Gastrointestinal Cancers, Gastrointestinal Tumors, Hepatocellular ...

View full profile